Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001349978 | SCV001544348 | uncertain significance | Developmental and epileptic encephalopathy, 36 | 2022-08-23 | criteria provided, single submitter | clinical testing | This variant, c.3029_3031del, results in the deletion of 1 amino acid(s) of the ALG13 protein (p.Gln1010del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs770600982, gnomAD 0.006%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with ALG13-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV004546638 | SCV005042080 | uncertain significance | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | ALG13: PM4:Supporting |
Clinical Genetics Laboratory, |
RCV004546638 | SCV005198480 | uncertain significance | not provided | 2022-05-27 | criteria provided, single submitter | clinical testing |